Anuj V. Peddada

Two-Year Intention-to-Treat Analysis for Tumor Outcome in Patients Treated with Avasopasem for Oral Cavity and Oral Pharynx Primaries

Neal Dunlap, C.M. Lee, J.R. Kelley, G.V. Walker et autres

us, ca (code pays fourni par la source)

High Dose “HDR-Like” Prostate SBRT: PSA 10-Year Results From a Mature, Multi-Institutional Clinical Trial

Trevor J. Royce, Donald B. Fuller, Ronald C. Chen, James R. Gray et autres

us (code pays fourni par la source)

High Dose “HDR-Like” Prostate SBRT: PSA 10-Year Results From a Mature, Multi-Institutional Clinical Trial

Donald B. Fuller, Tami Crabtree, Brent L. Kane, Clinton A. Medbery et autres

us, sg (code pays fourni par la source)

Tumor Outcomes of Phase IIb, Randomized, Double-Blind Trial of GC4419 Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiotherapy and Cisplatin For Head and Neck Cancer

Carryn M. Anderson, C.M. Lee, Deborah Saunders, A.E. Curtis et autres

us, ca (code pays fourni par la source)

Nephron-Sparing Robotic Radiosurgical Therapy for Primary Renal Cell Carcinoma: Single-Institution Experience and Review of the Literature

Anuj V. Peddada, Danyon J. Anderson, Olivier Blasi, Kiernan McCollough et autres

us (code pays fourni par la source)

HDR-Like Prostate Stereotactic Body Radiotherapy: Evaluation of PSA kinetics, Clinical Relapse-free Survival and Adverse Events Beyond 5 years in a Multi-institutional Study

Donald B. Fuller, Brent L. Kane, T. Crabtree, Clinton A. Medbery et autres

us (code pays fourni par la source)

Erectile Function after High-Dose-Rate Brachytherapy-like Stereotactic Body Radiation Therapy for Organ-Confined Prostate Cancer

Donald B. Fuller, Brent L. Kane, K. Underhill, J. R. Gray et autres

us (code pays fourni par la source)

Patient and Dosimetric Predictors of Genitourinary and Bowel Quality of Life After Prostate SBRT: Secondary Analysis of a Multi-institutional Trial

Kyle Wang, Ronald C. Chen, Brent L. Kane, Clinton A. Medbery et autres

us (code pays fourni par la source)

Phase 2 Multicenter Trial of Heterogeneous-dosing Stereotactic Body Radiotherapy for Low- and Intermediate-risk Prostate Cancer: 5-year Outcomes

Donald B. Fuller, Aaron D. Falchook, Tami Crabtree, Brent L. Kane et autres

us (code pays fourni par la source)

OC-0504: 5-year efficacy and quality of life outcomes of a multi-institutional HDR-Like prostate SBRT trial

D. Fuller, Brent L. Kane, Clinton A. Medbery, K. Underhill et autres

be, pt (code pays fourni par la source)

Stereotactic Body Radiotherapy (SBRT) for liver metastasis – clinical outcomes from the international multi-institutional RSSearch® Patient Registry

Anand Mahadevan, Oliver Blanck, Rachelle Lanciano, Anuj V. Peddada et autres

us, de (code pays fourni par la source)

Stereotactic Body Radiotherapy for Liver Metastases - Overall Survival and Local Control from the RSSearch® Patient Registry

Sanjeev Sharma, Joanne Davis, Anand Mahadevan, Rachelle Lanciano et autres